Aqr Capital Management LLC Seres Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

  • $58.2 Billion
  • Q1 2024

A detailed history of Aqr Capital Management LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 166,887 shares of MCRB stock, worth $120,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
166,887
Previous 27,662 503.31%
Holding current value
$120,158
Previous $38,000 236.84%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.75 - $1.56 $104,418 - $217,191
139,225 Added 503.31%
166,887 $128,000
Q4 2023

Feb 14, 2024
BUY
$0.93 - $2.15 $11,746 - $27,156
12,631 Added 84.03%
27,662 $38,000
Q3 2023

Nov 14, 2023
SELL
$2.33 - $5.07 $10,895 - $23,707
-4,676 Reduced 23.73%
15,031 $35,000
Q2 2023

Aug 14, 2023
BUY
$4.67 - $6.55 $92,031 - $129,080
19,707 New
19,707 $94,000
Q3 2022

Nov 14, 2022
SELL
$3.5 - $7.2 $340,875 - $701,229
-97,393 Reduced 27.72%
253,919 $1.63 Million
Q2 2022

Aug 15, 2022
BUY
$2.7 - $7.62 $229,240 - $646,968
84,904 Added 31.87%
351,312 $1.21 Million
Q1 2022

May 16, 2022
BUY
$6.3 - $8.84 $1.39 Million - $1.95 Million
220,109 Added 475.41%
266,408 $1.9 Million
Q4 2021

Feb 14, 2022
SELL
$6.02 - $11.43 $283,138 - $537,587
-47,033 Reduced 50.39%
46,299 $386,000
Q3 2021

Nov 15, 2021
BUY
$5.46 - $22.6 $341,086 - $1.41 Million
62,470 Added 202.42%
93,332 $650,000
Q2 2021

Aug 16, 2021
BUY
$18.46 - $24.36 $190,876 - $251,882
10,340 Added 50.38%
30,862 $736,000
Q1 2021

May 17, 2021
SELL
$17.66 - $28.92 $406,021 - $664,899
-22,991 Reduced 52.84%
20,522 $423,000
Q4 2020

Feb 16, 2021
SELL
$23.25 - $37.73 $400,853 - $650,502
-17,241 Reduced 28.38%
43,513 $1.07 Million
Q3 2020

Nov 16, 2020
BUY
$3.74 - $28.74 $227,219 - $1.75 Million
60,754 New
60,754 $1.72 Million
Q1 2020

May 15, 2020
SELL
$2.64 - $3.82 $377,889 - $546,794
-143,140 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$2.99 - $4.42 $274,185 - $405,318
-91,701 Reduced 39.05%
143,140 $494,000
Q3 2019

Nov 14, 2019
BUY
$2.29 - $4.16 $537,785 - $976,938
234,841 New
234,841 $942,000

Others Institutions Holding MCRB

# of Institutions
100
Shares Held
62.7M
Call Options Held
36.9K
Put Options Held
476K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email